Trial Profile
A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Serotonin uptake inhibitors
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 14 Jun 2019 Status changed from recruiting to completed.
- 21 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Mar 2019.
- 21 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2019.